// App-Quantinova.ai

: Evaluating the relationship between soluble triggering receptor expressed on myeloid cells 2 (sTREM2) and pathological substrates of Alzheimer’s Disease (AD).

Researchers

Presenter

  • Malak Wahdan

Principal Investigators

  • Sanara Raza

  • Nicholas R Livingston

  • Joseph Nowell

  • Paul Edison

Medical Centers

  • Imperial College, London, UK

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Central Nervous System (CNS)

Disease

  • Mild cognitive impairment

  • Alzheimer's disease

Biomarkers

  • 18F-fluorodeoxyglucose

  • Cerebrospinal fluid

Drug/Treatment

  • AV-1451

  • AV-45

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved